PSMA-targeted imaging of prostate cancer： evolution of a success story

Management of prostate cancer patients with biochemical relapse has long hampered due to insufficient capability to detect and localize recurrent disease with available imaging modalities such as CT, MRI, or bone scintigraphy. Recent advances in functional imaging, namely, PET and SPEGT imaging, wit...

Full description

Saved in:
Bibliographic Details
Published in:Asian journal of andrology 2017-05, Vol.19 (3), p.388-388
Main Authors: Maurer, Tobias, Eiber, Matthias
Format: Article
Language:English
Subjects:
Antigens
CAT scans
Diagnosis
Genetic aspects
Invited
Medical imaging
Metastasis
Patients
Pharmaceutical industry
Physiological aspects
Prostate cancer
Prostate specific antigen
Surgery
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Management of prostate cancer patients with biochemical relapse has long hampered due to insufficient capability to detect and localize recurrent disease with available imaging modalities such as CT, MRI, or bone scintigraphy. Recent advances in functional imaging, namely, PET and SPEGT imaging, with novel tracers targeting the prostate-specific membrane antigen （PSMA） have led to a surge in imaging in prostate cancer patients with biochemical relapse since was able to reveal sites of recurrence in a claritv not seen before.
ISSN:1008-682X
1745-7262
DOI:10.4103/aja.aja_2_17